Cargando…
Statins, Muscle Disease and Mitochondria
Cardiovascular disease (CVD) accounts for >17 million deaths globally every year, and this figure is predicted to rise to >23 million by 2030. Numerous studies have explored the relationship between cholesterol and CVD and there is now consensus that dyslipidaemia is a causal factor in the pat...
Autores principales: | Ramachandran, Radha, Wierzbicki, Anthony S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575577/ https://www.ncbi.nlm.nih.gov/pubmed/28757597 http://dx.doi.org/10.3390/jcm6080075 |
Ejemplares similares
-
Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target?
por: Morel, Jerome, et al.
Publicado: (2014) -
Mitochondria-Targeted Antioxidants and Skeletal Muscle Function
por: Broome, Sophie C., et al.
Publicado: (2018) -
The role of mitochondria in redox signaling of muscle homeostasis
por: Ji, Li Li, et al.
Publicado: (2020) -
Statin-induced Myopathy in Skeletal Muscle: the Role of Exercise
por: Kwak, Hyo-Bum
Publicado: (2014) -
Curcumin: An effective adjunct in patients with statin‐associated muscle symptoms?
por: Sahebkar, Amirhossein, et al.
Publicado: (2016)